How to Get Insurance to Cover Ozempic, Wegovy, Mounjaro & Zepbound
May 2026 | BetterNewLives.com
GLP-1 medications have some of the strongest clinical evidence in modern medicine for weight loss and metabolic health — and some of the most inconsistent insurance coverage. Whether your claim gets approved often comes down to how your prescription is written, how your diagnosis is documented, and whether you follow a specific process. This guide walks through all of it.
Coverage by Insurance Type
| Insurance Type | Diabetes Label Coverage | Weight-Loss Label Coverage | Notes |
|---|---|---|---|
| Commercial (employer-sponsored) | Often covered | Varies widely | Check your formulary. Many plans added weight-loss coverage in 2024–2026 due to employer pressure. |
| ACA Marketplace plans | Often covered | Increasingly common | Metal tier matters — Silver/Gold plans more likely to include anti-obesity medications than Bronze. |
| Medicare Part D | Covered (diabetes) | Not covered | Federal law prohibits Part D coverage of weight-loss drugs. Diabetes-indication prescriptions are covered. |
| Medicaid | State-dependent | State-dependent | Coverage varies dramatically by state. Some states added GLP-1 coverage; others have strict PA requirements. |
| Self-funded employer plans | Plan-specific | Plan-specific | Self-funded plans set their own formulary and can exclude drugs commercial plans cover. Check your SPD. |
Step-by-Step: Getting Prior Authorization Approved
Prior authorization (PA) is required by most plans before they'll cover a GLP-1 medication. It's not a denial — it's a gate. Most PAs are approved if submitted correctly the first time. Here's the process:
- Confirm your plan's PA criteria before your appointment. Call the member services number on your insurance card and ask: "What are the prior authorization criteria for Wegovy/Zepbound?" They will read you the specific requirements — BMI threshold, required comorbidities, prior treatment documentation. Write them down. Your doctor needs to document exactly these criteria.
- Have your doctor document everything in the clinical notes. The PA is only as strong as the medical record supporting it. Your doctor's notes should explicitly state your current BMI, any comorbidities (type 2 diabetes, hypertension, sleep apnea, PCOS, cardiovascular disease), prior weight-loss attempts and their outcomes, and the clinical rationale for this specific medication. Vague notes get denied; specific clinical documentation gets approved.
- Ask your doctor's office to submit the PA — not just the prescription. Many practices have a PA coordinator or use electronic PA systems. Make sure someone is actively submitting the prior authorization with supporting clinical records, not just sending the prescription to the pharmacy and hoping it goes through.
- Follow up in 3–5 business days. PA decisions typically take 3–7 business days. If you haven't heard back, call your insurer and ask for the PA status by the reference number your doctor's office should have given you.
- If approved: confirm the copay and tier. Ask your pharmacy to run a test claim before you go to pick it up. GLP-1 medications often land on Tier 3 or Tier 4 formulary, meaning the copay can be $50–$200 even with coverage. The manufacturer savings card can bring this down to $25.
How to Appeal a Denial
A denial is not the end. Most people who appeal GLP-1 denials — with proper documentation — either win the appeal or find a viable alternative during the process. Here's how to do it effectively:
Step 1: Request the denial in writing
You are legally entitled to a written explanation of any insurance denial. This document is critical — it tells you the exact reason for denial, which determines your appeal strategy. Common denial reasons: "not medically necessary," "not on formulary," "step therapy required," or "indication not covered."
Step 2: Match your appeal to the denial reason
Each denial reason requires a different response:
- "Not medically necessary" — Have your physician write a detailed medical necessity letter documenting your BMI, comorbidities, failed prior treatments, and the clinical evidence supporting GLP-1 therapy for your specific situation. Reference clinical guidelines (ADA Standards of Care, AACE guidelines) explicitly.
- "Step therapy required" — Your insurer wants proof you tried cheaper alternatives first. Document any prior weight-loss medications, programs, or dietary interventions. If there's a clinical reason you can't try the step therapy drug (contraindication, prior failure, allergy), your physician should state that clearly.
- "Not on formulary" — Request a formulary exception. This is a separate process from a standard appeal and has its own approval pathway. Your physician needs to state why the formulary alternative is inadequate for your clinical situation.
- "Indication not covered" — If your plan excludes weight-loss drugs, consider whether a diabetes or prediabetes diagnosis applies. A prescriber can legitimately prescribe a diabetes-indication drug (Ozempic, Mounjaro) for a patient with type 2 diabetes or prediabetes, even if weight loss is also a goal.
Step 3: Submit your appeal with complete documentation
Include: the written denial, your physician's appeal letter, relevant lab results (HbA1c, lipid panel, fasting glucose), any specialist notes, and a patient statement describing the impact of the condition on your daily life. Most insurers accept appeals by fax, mail, or online portal — confirm which channel is fastest for urgent appeals.
Step 4: Request an external review if the internal appeal fails
Federal law (and most state laws) requires insurers to offer an independent external review when an internal appeal is denied. An independent organization — not your insurer — reviews the case. External reviews overturn internal denials at a meaningful rate, especially when new clinical documentation is presented. This costs nothing to request.
Employer-Sponsored Plans: A Special Case
If you get insurance through your employer, the coverage decision is made by your employer — not your insurer. Large employers (500+ employees) typically self-fund their health plan, meaning they directly pay claims and set their own formulary. Your insurer (UnitedHealth, Aetna, Cigna, etc.) is just administering the plan, not making coverage decisions.
This means you can appeal directly to your employer's HR or benefits department, not just through the standard insurer appeal process. A growing number of large employers have added GLP-1 weight-loss coverage in 2024–2026 as evidence of workplace health ROI has mounted. If you work for a large company and your plan doesn't cover GLP-1 medications for weight loss, it may be worth asking your HR department whether coverage is being considered — especially if other employees have the same concern.
When Insurance Doesn't Work Out: Your Next Steps
If you've exhausted your insurance options, you're not out of options. The cost landscape for GLP-1 medications has multiple pathways that many patients don't know about: